Literature DB >> 27855953

Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative.

Philip A Ades1, Steven J Keteyian2, Janet S Wright3, Larry F Hamm4, Karen Lui5, Kimberly Newlin6, Donald S Shepard7, Randal J Thomas8.   

Abstract

The primary aim of the Million Hearts initiative is to prevent 1 million cardiovascular events over 5 years. Concordant with the Million Hearts' focus on achieving more than 70% performance in the "ABCS" of aspirin for those at risk, blood pressure control, cholesterol management, and smoking cessation, we outline the cardiovascular events that would be prevented and a road map to achieve more than 70% participation in cardiac rehabilitation (CR)/secondary prevention programs by the year 2022. Cardiac rehabilitation is a class Ia recommendation of the American Heart Association and the American College of Cardiology after myocardial infarction or coronary revascularization, promotes the ABCS along with lifestyle counseling and exercise, and is associated with decreased total mortality, cardiac mortality, and rehospitalizations. However, current participation rates for CR in the United States generally range from only 20% to 30%. This road map focuses on interventions, such as electronic medical record-based prompts and staffing liaisons that increase referrals of appropriate patients to CR, increase enrollment of appropriate individuals into CR, and increase adherence to longer-term CR. We also calculate that increasing CR participation from 20% to 70% would save 25,000 lives and prevent 180,000 hospitalizations annually in the United States.
Copyright © 2016 Mayo Foundation for Medical Education and Research. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27855953      PMCID: PMC5292280          DOI: 10.1016/j.mayocp.2016.10.014

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  53 in total

1.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

Review 2.  Alternative models of cardiac rehabilitation: a systematic review.

Authors:  Robyn A Clark; Aaron Conway; Vanessa Poulsen; Wendy Keech; Rosy Tirimacco; Phillip Tideman
Journal:  Eur J Prev Cardiol       Date:  2013-08-13       Impact factor: 7.804

Review 3.  Cardiac rehabilitation participation in underserved populations. Minorities, low socioeconomic, and rural residents.

Authors:  Hugo E Valencia; Patrick D Savage; Philip A Ades
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 Jul-Aug       Impact factor: 2.081

4.  Million hearts--where population health and clinical practice intersect.

Authors:  Janet S Wright; Hilary K Wall; Peter A Briss; Michael Schooley
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-07-01

5.  Full coverage for preventive medications after myocardial infarction.

Authors:  Niteesh K Choudhry; Jerry Avorn; Robert J Glynn; Elliott M Antman; Sebastian Schneeweiss; Michele Toscano; Lonny Reisman; Joaquim Fernandes; Claire Spettell; Joy L Lee; Raisa Levin; Troyen Brennan; William H Shrank
Journal:  N Engl J Med       Date:  2011-11-14       Impact factor: 91.245

6.  Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.

Authors:  James C Fang; Gregory A Ewald; Larry A Allen; Javed Butler; Cheryl A Westlake Canary; Monica Colvin-Adams; Michael G Dickinson; Phillip Levy; Wendy Gattis Stough; Nancy K Sweitzer; John R Teerlink; David J Whellan; Nancy M Albert; Rajan Krishnamani; Michael W Rich; Mary N Walsh; Mark R Bonnell; Peter E Carson; Michael C Chan; Daniel L Dries; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Stephanie Moore; Jo E Rodgers; Joseph G Rogers; Amanda R Vest; Michael M Givertz
Journal:  J Card Fail       Date:  2015-05-04       Impact factor: 5.712

7.  Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery.

Authors:  Jose A Suaya; Donald S Shepard; Sharon-Lise T Normand; Philip A Ades; Jeffrey Prottas; William B Stason
Journal:  Circulation       Date:  2007-09-24       Impact factor: 29.690

8.  Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery.

Authors:  L Vanhees; R Fagard; L Thijs; A Amery
Journal:  Am J Cardiol       Date:  1995-11-15       Impact factor: 2.778

Review 9.  Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis.

Authors:  Lindsey Anderson; Neil Oldridge; David R Thompson; Ann-Dorthe Zwisler; Karen Rees; Nicole Martin; Rod S Taylor
Journal:  J Am Coll Cardiol       Date:  2016-01-05       Impact factor: 24.094

10.  Cardiac rehabilitation patient and organizational factors: what keeps patients in programs?

Authors:  Karam I Turk-Adawi; Neil B Oldridge; Sergey S Tarima; William B Stason; Donald S Shepard
Journal:  J Am Heart Assoc       Date:  2013-10-21       Impact factor: 5.501

View more
  101 in total

1.  Geographic Variation in Cardiac Rehabilitation Participation in Medicare and Veterans Affairs Populations: Opportunity for Improvement.

Authors:  Alexis L Beatty; Michael Truong; David W Schopfer; Hui Shen; Justin M Bachmann; Mary A Whooley
Journal:  Circulation       Date:  2018-01-05       Impact factor: 29.690

2.  Factors Influencing the Impact of Depressive Symptoms on Physical Functional Capacity After Cardiac Rehabilitation.

Authors:  Kelly L Wierenga; Shirley M Moore; Jintao Liu; Abdus Sattar
Journal:  Rehabil Nurs       Date:  2019-05-17       Impact factor: 1.625

Review 3.  Barriers to Cardiac Rehabilitation in Ethnic Minority Groups: A Scoping Review.

Authors:  Lais Manata Vanzella; Paul Oh; Maureen Pakosh; Gabriela L M Ghisi
Journal:  J Immigr Minor Health       Date:  2021-01-25

Review 4.  The role of cardiac rehabilitation in patients with heart disease.

Authors:  Sean R McMahon; Philip A Ades; Paul D Thompson
Journal:  Trends Cardiovasc Med       Date:  2017-02-15       Impact factor: 6.677

Review 5.  Effect of Socioeconomic Status on Propensity to Change Risk Behaviors Following Myocardial Infarction: Implications for Healthy Lifestyle Medicine.

Authors:  Diann E Gaalema; Rebecca J Elliott; Zachary H Morford; Stephen T Higgins; Philip A Ades
Journal:  Prog Cardiovasc Dis       Date:  2017-01-05       Impact factor: 8.194

6.  Feasibility of integrating survivors of stroke into cardiac rehabilitation: A mixed methods pilot study.

Authors:  Elizabeth W Regan; Reed Handlery; Jill C Stewart; Joseph L Pearson; Sara Wilcox; Stacy Fritz
Journal:  PLoS One       Date:  2021-03-29       Impact factor: 3.240

Review 7.  Cardiac Rehabilitation for Secondary Prevention of Cardiovascular Disease: 2019 Update.

Authors:  Randal J Thomas; Hsu-Hang Huang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-09-05

8.  Tracking Cardiac Rehabilitation Participation and Completion Among Medicare Beneficiaries to Inform the Efforts of a National Initiative.

Authors:  Matthew D Ritchey; Sha Maresh; Jessica McNeely; Thomas Shaffer; Sandra L Jackson; Steven J Keteyian; Clinton A Brawner; Mary A Whooley; Tiffany Chang; Haley Stolp; Linda Schieb; Janet Wright
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-01-14

Review 9.  Cardiac Rehabilitation for Women: A Systematic Review of Barriers and Solutions.

Authors:  Marta Supervía; Jose R Medina-Inojosa; Colin Yeung; Francisco Lopez-Jimenez; Ray W Squires; Carmen M Pérez-Terzic; LaPrincess C Brewer; Shawn E Leth; Randal J Thomas
Journal:  Mayo Clin Proc       Date:  2017-03-13       Impact factor: 7.616

Review 10.  Approaches to improving exercise capacity in patients with left ventricular assist devices: an area requiring further investigation.

Authors:  Richard Severin; Ahmad Sabbahi; Cemal Ozemek; Shane Phillips; Ross Arena
Journal:  Expert Rev Med Devices       Date:  2019-09-06       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.